Question 1

What are the IVF success rates at Polmedis?

Accepted Answer

Polmedis reports pregnancy and birth rates for in‑vitro fertilisation across several years. In 2012 the clinic achieved a 45 % clinical pregnancy rate per treatment cycle and a 36 % live‑birth rate. After a policy shift in 2014 the rates were 25 % pregnancies and 24 % births per cycle. More recent data show continued improvement: in 2016 the pregnancy rate per cycle exceeded 37 % with a 30 % birth rate, while the pregnancy rate per embryo transfer was above 39 % and the birth rate 31 %. In 2017 the clinic recorded a pregnancy rate per cycle of over 38 % and a pregnancy rate per transfer of over 40 %. These figures are based on the clinic’s own monitoring and are submitted to the European Society of Human Reproduction and Embryology (ESHRE) registry, ensuring independent verification.

Question 2

Does Polmedis offer egg donation for IVF treatment?

Accepted Answer

Yes, Polmedis provides egg donation as part of its IVF programme. The clinic participates in the national government‑funded in‑vitro treatment scheme, which covers cycles using anonymous donor eggs for women up to 45 years of age. Donor‑egg cycles are fully integrated with the clinic’s IVF laboratory, allowing fresh or frozen donor oocytes to be fertilised and transferred. The programme also includes comprehensive donor screening, legal counselling and psychological assessment to ensure safe and ethical use of donor gametes.

Question 3

What IVF laboratory technology does Polmedis use?

Accepted Answer

Polmedis’ IVF laboratory is equipped with several cutting‑edge technologies. The centre performs IMSI, which uses high‑magnification microscopy for detailed sperm selection, and PICSI, which selects sperm that bind to hyaluronic acid. Sperm preparation is enhanced with the ZyMot Multi chip system for motility‑based selection, while MACS (magnetic‑activated cell sorting) removes apoptotic sperm cells. Embryos can undergo assisted hatching using a precise laser system. The laboratory operates under ISO 9001 quality management and holds an ESHRE clinical embryology certification, confirming adherence to European standards for safety and efficacy.

Question 4

Who are the fertility doctors and specialists at Polmedis?

Accepted Answer

Polmedis is led by Dr. Artur Polak, a medical doctor and specialist in gynaecology‑obstetrics with more than 20 years of experience in assisted reproduction and an ESHRE embryology certification. The medical team also includes Dr. Alicja Polak, a gynaecology‑obstetrics specialist, and Dr. Katarzyna Tomczyk, another specialist with seven years of infertility treatment experience. Laboratory expertise is provided by embryologists mgr Malwina Stasiak and Dr Maurycy Pawlak, both holding ESHRE clinical embryology certificates. Supporting staff includes Marta Wierzbowicz (medical registrar) and Maria Wójcińska (midwife). Together they form a multidisciplinary team that covers diagnosis, hormonal stimulation, IVF, ICSI, embryo culture and transfer, and comprehensive patient care.

Question 5

What is the history and background of Polmedis?

Accepted Answer

Polmedis was founded in 1998 by Dr. Artur Polak, a medical doctor and researcher, marking the start of the first infertility‑treatment centre in Lower Silesia. The clinic introduced in‑vitro fertilisation in 2002 after extensive training at Ben‑Gurion University and Soroka Medical Centre in Israel under Prof. Gad Potaschnik. Milestones include the region’s first child born after frozen‑embryo transfer, the first pregnancy using anonymous donor gametes, and the first ICSI conception in the area. Polmedis reports its outcomes to the European Centre for Monitoring of ESHRE, and its laboratory holds an ESHRE embryology certification. The centre operates as part of the non‑public health institution “Polak” and continues to expand its assisted‑reproduction programmes.

Question 6

What is the maximum age for IVF treatment at Polmedis?

Accepted Answer

Polmedis follows the age limits set by the Polish government IVF programme. For cycles using the couple’s own gametes, women may be treated up to 42 years of age, while men are accepted up to 55 years. When donor eggs are used, the female age limit extends to 45 years, and the same 55‑year limit applies to male partners. The same upper age (45 years for women) is applied to embryo adoption cycles. These policies are designed to balance treatment efficacy with safety, and the clinic may consider individual clinical circumstances on a case‑by‑case basis.

Question 7

What fertility treatments and services does Polmedis offer?

Accepted Answer

Polmedis provides a full spectrum of assisted reproduction services. Core IVF programmes include conventional in‑vitro fertilisation, ICSI (intracytoplasmic sperm injection) and advanced variants such as IMSI (intracytoplasmic morphologically selected sperm injection) and PICSI (physiological ICSI). The clinic also offers intra‑uterine insemination (IUI) with partner or donor sperm, egg freezing and sperm cryopreservation for fertility preservation, and donor‑egg IVF using anonymous donors. Additional options comprise pre‑implantation genetic testing, assisted hatching, embryo adoption, hormonal stimulation protocols, and comprehensive diagnostic work‑ups including HSG, hormonal panels and genetic testing. All procedures are coordinated by the clinic’s fertility specialists and embryology laboratory.

Polmedis.Klinika leczenia niepłodności

About Polmedis.Klinika leczenia niepłodności

check_circleWhy choose Polmedis.Klinika leczenia niepłodności?

warningWhat to watch out for at Polmedis.Klinika leczenia niepłodności?

Fertility Treatment Prices at Polmedis.Klinika leczenia niepłodności

Polmedis.Klinika leczenia niepłodności — Patient Reviews

Polmedis.Klinika leczenia niepłodności — FAQ

Contact & Location

More Fertility Clinics in Poland

Kliniki i Laboratoria Medyczne INVICTA

Klinika Bocian Poznań - Leczenie niepłodności, Badanie nasienia, In vitro

Klinika Bocian Białystok - Leczenie niepłodności, In vitro